Greenlight Capital’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $101K | Hold |
136,350
| – | – | ﹤0.01% | 37 |
|
|
2023
Q3 | $119K | Hold |
136,350
| – | – | 0.01% | 35 |
|
|
2023
Q2 | $255K | Sell |
136,350
-1
| -0% | -$2 | 0.01% | 36 |
|
|
2023
Q1 | $505K | Hold |
136,351
| – | – | 0.03% | 35 |
|
|
2022
Q4 | $519K | Hold |
136,351
| – | – | 0.04% | 33 |
|
|
2022
Q3 | $1.08M | Hold |
136,351
| – | – | 0.08% | 33 |
|
|
2022
Q2 | $2.86M | Hold |
136,351
| – | – | 0.22% | 32 |
|
|
2022
Q1 | $5.13M | Hold |
136,351
| – | – | 0.33% | 30 |
|
|
2021
Q4 | $7.66M | Hold |
136,351
| – | – | 0.44% | 28 |
|
|
2021
Q3 | $9.84M | Hold |
136,351
| – | – | 0.66% | 23 |
|
|
2021
Q2 | $13.1M | Buy |
136,351
+35,000
| +35% | +$3.35M | 0.82% | 24 |
|
|
2021
Q1 | $15M | Hold |
101,351
| – | – | 1.04% | 22 |
|
|
2020
Q4 | $14.2M | Hold |
101,351
| – | – | 0.85% | 22 |
|
|
2020
Q3 | $15.4M | Buy |
101,351
+6,190
| +7% | +$940K | 1.26% | 19 |
|
|
2020
Q2 | $16.7M | Buy |
95,161
+18,238
| +24% | +$3.2M | 1.81% | 12 |
|
|
2020
Q1 | $11M | Hold |
76,923
| – | – | 1.56% | 14 |
|
|
2019
Q4 | $11.1M | Hold |
76,923
| – | – | 0.82% | 16 |
|
|
2019
Q3 | $7.68M | Buy |
+76,923
| New | +$7.68M | 0.55% | 19 |
|